Schramm B - Search Results

1

Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses.

Pinoges L, Schramm B, Poulet E, Balkan S, Szumilin E, Ferreyra C, Pujades-Rodríguez M. Pinoges L, et al. Among authors: schramm b. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):527-35. doi: 10.1097/QAI.0000000000000513. J Acquir Immune Defic Syndr. 2015. PMID: 25585301

2

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, Chanchhaya N, Ferradini L, Balkan S. Pujades-Rodríguez M, et al. Among authors: schramm b. Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19. Trop Med Int Health. 2011. PMID: 21087376 Free article.

3

Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.

Ben-Farhat J, Schramm B, Nicolay N, Wanjala S, Szumilin E, Balkan S, Pujades-Rodríguez M. Ben-Farhat J, et al. Among authors: schramm b. Trop Med Int Health. 2017 Mar;22(3):340-350. doi: 10.1111/tmi.12830. Epub 2017 Jan 26. Trop Med Int Health. 2017. PMID: 27992677 Free article.

4

High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients.

Bossard C, Schramm B, Wanjala S, Jain L, Mucinya G, Opollo V, Wiesner L, van Cutsem G, Poulet E, Szumilin E, Ellman T, Maman D. Bossard C, et al. Among authors: schramm b. J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):883-888. doi: 10.1097/QAI.0000000000002689. J Acquir Immune Defic Syndr. 2021. PMID: 33852504 Free PMC article.

5

HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.

Fily F, Ayikobua E, Ssemwanga D, Nicholas S, Kaleebu P, Delaugerre C, Pasquier E, Amoros Quiles I, Balkan S, Schramm B. Fily F, et al. Among authors: schramm b. Trop Med Int Health. 2018 Oct;23(10):1075-1083. doi: 10.1111/tmi.13131. Trop Med Int Health. 2018. PMID: 30058269 Free article.

6

Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I, Szumilin E, Gueguen M, Schramm B. Nicholas S, et al. Among authors: schramm b. J Int AIDS Soc. 2019 Aug;22(8):e25387. doi: 10.1002/jia2.25387. J Int AIDS Soc. 2019. PMID: 31441242 Free PMC article.

7

"We give them threatening advice…": expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi.

Burns R, Magalasi D, Blasco P, Szumilin E, Pasquier E, Schramm B, Wringe A. Burns R, et al. Among authors: schramm b. J Int AIDS Soc. 2020 Mar;23(3):e25459. doi: 10.1002/jia2.25459. J Int AIDS Soc. 2020. PMID: 32124554 Free PMC article.

8

Implementation and operational feasibility of SAMBA I HIV-1 semi-quantitative viral load testing at the point-of-care in rural settings in Malawi and Uganda.

Gueguen M, Nicholas S, Poulet E, Schramm B, Szumilin E, Wolters L, Wapling J, Ajule E, Rakesh A, Mwenda R, Kiyaga C, Balkan S. Gueguen M, et al. Among authors: schramm b. Trop Med Int Health. 2021 Feb;26(2):184-194. doi: 10.1111/tmi.13519. Epub 2020 Dec 3. Trop Med Int Health. 2021. PMID: 33159822 Free article.

9

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.

Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G, Bitilinyu-Bangoh JE, Storto A, Lê MP, Abdi B, Ousley J, Kalua T, Calvez V, Jahn A, Marcelin AG, Szumilin E. Schramm B, et al. Lancet HIV. 2022 Aug;9(8):e544-e553. doi: 10.1016/S2352-3018(22)00136-9. Lancet HIV. 2022. PMID: 35905753 Free article.

10

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Dhorda M, Boum Y 2nd, Sundaygar T, Zolia YM, Jones JJ, Comte E, Houzé P, Jullien V, Carn G, Kiechel JR, Ashley EA, Guérin PJ. Schramm B, et al. Malar J. 2013 Jul 17;12:251. doi: 10.1186/1475-2875-12-251. Malar J. 2013. PMID: 23866774 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters